NEU 3.50% $14.05 neuren pharmaceuticals limited

He was put in by Walker when QRX failed FDA hurdle and the share...

  1. 60 Posts.
    He was put in by Walker when QRX failed FDA hurdle and the share price plummeted. There to provide expertise on wrap up of IP I think, helping the old fulla/Hancox out of a jam IMO.

    The two companies share an investor/Walker. No link between their technologies, which is fortunate for the NEU investors.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.